Showing session: reset
Educational Session 2: PI3K and MEK Pathway Inhibitors
- Sort by:
- Browse by:
- Permission not
granted for presentation
BRAF and RAS signaling in melanoma: From basic biology to clinical exploitation
Richard M. Marais
Cancer Research UK Manchester Institute, Manchester, United Kingdom
- Free
- Unknown permission
for presentation
Title to be announced
Neal Rosen
Mem. Sloan-Kettering Cancer Ctr., New York, NY, United States
- Permission not
granted for presentation
Matrix-dependent adaptive resistance to targeted therapy
Joan S. Brugge
Harvard Medical School, Boston, MA, United States